P. M. A. Calverley (Liverpool, United Kingdom), H. Ghedira (Ariana, Tunisia)
The intensity of dyspnoea in COPD patients before and after specialized rehabilitation
L. Milojkovic (Sokobanja, Serbia And Montenegro)
|  |
Corticosteroid and long acting beta agonist combination inhalers in COPD: the right device for the right patient?
J. Mason, J. Sparrow, R. M. Angus (Liverpool, United Kingdom)
| |
Skeletal muscle gene expression profiling before and after training in COPD patients with normal BMI, low BMI and a group of healthy controls
R. Rabinovich, S. Kalko, P. Jares, J. A. Barberà, J. Roca, R. Bastos (Barcelona, Spain)
| |
The effect of tiotropium bromide in a stable cohort of COPD patients in Portugal
J. Moita, R. Costa, C. Barbara, J. Cardoso, J. Ruiz, M. Sousa (Coimbra, Lisbon, Portugal; San Cugat, Spain)
| |
Reducing the use of inhaled corticosteroids in mild COPD patients treated in primary care by a training program in national guidelines and using a portable device to measure pulmonary function
A. Martin, N. Soler, J. Montserrat, E. Ballester, E. Gobartt, M. Miravitlles, A. Torres (Madrid, Barcelona, Spain)
| |
Pharmacological treatment of patient with stable COPD in primary care
M. Garcia, P. Carrasco, R. Jimenez, A. Martin, E. Gobartt, A. Gil (Madrid, Barcelona, Spain)
| |
Differential effects of acute correction of hypoxemia in COPD patients on exercise performance: physiological mechanisms
N. Heraud, F. Durand, C. Prefaut, A. Varray (Montpellier, Osseja, France)
| |
Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD
B. Sposato, M. Salvatore, M. M. Giovanna, R. Alberto, C. Elena, G. Aldo, M. Lia, P. Piero, F. Clemente (Grosseto, Roma, Italy)
| |
Using cardioselective beta-blockers in patients with cardiovascular diseases and COPD
I. V. Litvinova, J. V. Gavrilov, S. I. Ovcharenko, V. A. Sulimov, V. I. Makolkin (Moscow, Russian Federation)
| |
Nebulisation of alpha-tocopherol in COPD
G. K. Sharafutdinova, L. A. Nazyrova (Tashkent, Uzbekistan)
| |
COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity
A. A. Denisenko, O. V. Dudina, V. I. Trofimov (St. Petersburg, Russian Federation)
| |
Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease (COPD)
O. Lorenzo, J. Abreu, C. Hernandez, P. Abreu, N. Lorenzo (La Laguna, Spain)
| |
Treatment of COPD: comparing the effects of inhaled steroids with N-acetylcysteine
F. J. van Overveld, U. A. Demkow, D. Górecka, W. A. De Backer, J. Zielinski (Antwerp, Belgium; , ; Warsaw, Poland)
| |
Safety of multiple-dose indacaterol, a novel 24-hour β2-agonist, in moderate to severe COPD
J. Beier, D. Jack, W. Bao, M. Higgins (Wiesbaden, Germany; Horsham, United Kingdom; East Hanover, United States Of America)
| |
The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease
G. Chen, C. Xie (Guangzhou, China)
| |
Effect of treatment on conditioning function indices in COPD
D. U. Gurckevich, S. F. Agarkov, J. N. Chaliy, O. A. Khramova (Donetsk, Ukraine)
| |
The problems of chronic obstructive pulmonary disease in Kyrgyzstan
T. M. Sooronbaev (Bishkek, Kyrgyzstan)
| |
The effects of inspiratory muscle strength training for young-old and old-old patients with COPD
C. H. Huang, C. W. Lee (Hualien, Taiwan, Province Of China)
| |
The confronting COPD survey in Central and Eastern Europe
H. Mullerova, J. Zielinski, J. Kozielski, J. Musil, J. B. Soriano (Greenford, United Kingdom; Warsaw, Zabrze, Poland; Prague, Czech Republic)
| |
Assessing support for COPD in Greece
M. Bonatou, Z. Marinaki, N. Tzanakis, D. Makris, M. Economaki, N. M. Siafakas (Heraklion, Greece)
| |